Asian Journal of Transfusion Science

ORIGINAL ARTICLE
Year
: 2013  |  Volume : 7  |  Issue : 2  |  Page : 109--115

Retrospective evaluation of adverse transfusion reactions following blood product transfusion from a tertiary care hospital: A preliminary step towards hemovigilance


Praveen Kumar1, Rakesh Thapliyal2, Poonam Coshic2, Kabita Chatterjee2 
1 Department of Laboratory Medicine, All India Institute of Medical Sciences, New Delhi, India
2 Department of Transfusion Medicine, All India Institute of Medical Sciences, New Delhi, India

Correspondence Address:
Praveen Kumar
Department of Lab Medicine, All India Institute of Medical Sciences, New Delhi - 110 029
India

Background: The goal of hemovigilance is to increase the safety and quality of blood transfusion. Identification of the adverse reactions will help in taking appropriate steps to reduce their incidence and make blood transfusion process as safe as possible. Aims : To determine the frequency and type of transfusion reactions (TRs) occurring in patients, reported to the blood bank at our institute. Materials and Methods : A retrospective review of all TRs reported to the blood bank at the All India Institute of Medical Sciences, between December 2007 and April 2012 was done. All the TRs were evaluated in the blood bank and classified using standard definitions. Results: During the study period a total of 380,658 bloods and blood components were issued by our blood bank. Out of the total 196 adverse reactions reported under the hemovigilance system, the most common type of reaction observed was allergic 55.1% (n = 108), followed by febrile non-hemolytic transfusion reaction (FNHTR) 35.7% (n = 70). Other less frequently observed reactions were Anaphylactoid reactions 5.1% (n = 10), Acute non-immune HTRs 2.6% (n = 5), Circulatory overload 0.5% (n = 1), Transfusion related acute lung injury 0.5% (n = 1), Delayed HTRs 0.5% (n = 1). Not a single case of bacterial contamination was observed. Conclusion: The frequency of TRs in our patients was found to be 0.05% (196 out of 380,658). This can be an underestimation of the true incidence because of under reporting. It should be the responsibility of the blood transfusion consultant to create awareness amongst their clinical counterpart about safe transfusion practices so that proper hemovigilance system can be achieved to provide better patient care.


How to cite this article:
Kumar P, Thapliyal R, Coshic P, Chatterjee K. Retrospective evaluation of adverse transfusion reactions following blood product transfusion from a tertiary care hospital: A preliminary step towards hemovigilance.Asian J Transfus Sci 2013;7:109-115


How to cite this URL:
Kumar P, Thapliyal R, Coshic P, Chatterjee K. Retrospective evaluation of adverse transfusion reactions following blood product transfusion from a tertiary care hospital: A preliminary step towards hemovigilance. Asian J Transfus Sci [serial online] 2013 [cited 2021 Sep 23 ];7:109-115
Available from: https://www.ajts.org/article.asp?issn=0973-6247;year=2013;volume=7;issue=2;spage=109;epage=115;aulast=Kumar;type=0